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Abstract Simple, specific, rapid and accurate UV-spectrophotometric 
methods have been developed using a solvent acetonitrile (50 %) to determine 
delafloxacin in bulk material and in laboratory mixture. “Method A” is zero 
order derivative UV- spectrophotometry using absorbance, “Method B” is 
zero order derivative UV-spectrophotometry using Area  Under  Curve (AUC) 
technique, “Method C” is first order derivative UV-spectrophotometry using 
amplitude, “Method D” is First Order Derivative UV-spectrophotometry-
AUC,“Method E” is Second Order Derivative UV-spectrophotometry using 
amplitude and “Method F” is second order derivative UV- spectrophotometry 
using (AUC)  technique. The developed methods have shown excellent results 
in terms of linearity and range, accuracy, precision and Limit of Detection 
(LOD) and Limit of Quantification (LOQ). In all Methods, delafloxacin obeyed 
linearity in the concentration range of 2 - 12 µg/mL with (r2 > 0.999). All these 
methods were applied for estimation of delafloxacin in laboratory mixture. All 
the above mentioned methods were validated considering linearity and range, 
accuracy, precision, ruggedness and sensitivity. 
Keywords: Delafloxacin; UV-Spectrophotometry; Zero order Derivative; 
First order Derivative;   Area under curve; Second Order Derivative
1. INTRODUCTION
Delafloxacin (DLF) is 1-(6-amino-3, 5-difluro-2-pyridyl)-8-chloro-6-fluoro-
7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid [1] (Figure 1). 
The ability of Delafloxacin, a fluoroquinolone, to form cleavable complexes 




which is able to inhibit these two enzymes in both Gram positive and negative 
bacteria [6]. It is primarily used to treat infections of skin and respiratory 
system [2]. In the literature, McEwen and co-workers have reported a LC-MS 
method for the analysis of delafloxacin and their metabolites in pooled urine, 
faeces and plasma [4]. 
The AUC method involves measurement of united value of area in the 
range of selected two wavelengths, 1 and 2. The wavelength range selection 
is a result of repeated observations until a linearity is achieved between AUC 
and concentration [5].
To our knowledge no method(s) were found in literature for determination 
of delafloxacin on bulk and formulation using derivative spectroscopic 
techniques. Therefore, our endeavor is to establish zero-, first- and second-
order derivative UV-Spectrophotometry using amplitude and also AUC 
techniques. Further, methods were validated as per ICH guidelines [3].
2. EXPERIMENTAL WORK
2.1 Materials 
Delafloxacin was received as free sample from Alkem Laboratories, Mumbai. 
All chemicals and reagents were purchased from Merck chemicals, Mumbai, 
India, of analytical grade.
2.2 Instrument
For present analysis, a double beam UV-VIS spectrophotometer (UV-2450, 
Shimadzu, Japan) was used, which was linked to computer installed with 
spectra manager software UV Probe 2.21 with 10 mm quartz cells. The spectra 
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were obtained with following set of instrumental parameters: wavelength range: 
400 - 200 nm; scan speed: medium; sampling interval: 10 nm; band width: 1.0 
nm; spectral slit width: 1 nm. An electronic balance (Model Shimadzu AUX 
120) was used for weighing purpose.
2.3 Preparation of Stock Standard Solution (SSS) 
The SSS was prepared by accurately weighing and dissolving 10 mg of delafloxacin 
in 100 ml of acetonitrile (50%) to achieve final concentration of 100 µg/mL. 
2.4 Methods A (Zero Order Spectrophotometry) and Method B (Zero 
order Spectrophotometry–AUC) 
From the stock standard solution, an appropriate volumes 0.2 – 1.2 mL were 
transferred into a series of 10 mL volumetric flasks, followed by their volume 
make up to obtain final concentration  ranging from 2 to 12 µg/mL. In Method 
A, absorbance was recorded at 285 nm while in Method B, area under curve 
was selected in the wavelength range of 269-300 nm. In method A, the linearity 
curve was plotted between concentration and absorbance while in method B, it 
was plotted between concentration and AUC. 
2.5 Methods C (First order derivative –UV Spectrophotometry and D 
(First order Derivative –UV Spectrophotometry-AUC) 
In Method C and D, spectra of above prepared solutions, in the range of 2 
-12 µg/ mL, were derivatized into first order using software UV-Probe 2.21 
with delta lambda 10 and scaling factor 10. In Method C, the amplitude was 
recorded at 295.50 nm while in Method D, AUC of the derivatized spectrum 
was studied at 288.50- 304.50 nm. The linearity curve was plotted between 
concentration and amplitude in Method C, while, on the other hand, in method 
D, it was plotted between concentration and AUC of first order derivative 
spectra between selected wavelengths. 
2.6 Methods E (Second order Derivative UV Spectrophotometry) and F 
(Second order Derivative UV Spectrophotometry-AUC) 
In method E and method F, spectra of above prepared delafloxacin solutions in 
the range of 2 - 12 µg/ mL were derivatized into second order using software 
UV-Probe 2.21 with delta lambda 10 and scaling factor 10. In “method E” the 
amplitudes were recorded at 285 nm while in “Method F” AUC was recorded 
in between two wavelengths 278-291 nm. The linearity curve was plotted 




plotted between concentration and AUC of second order spectra at selected 
wavelengths. 
2.7 Preparation of Delafloxacin Laboratory Mixture
Laboratory mixture was prepared with 100 mg of delafloxacin and common 
excipients.
3. VALIDATION OF METHOD
All developed methods, i.e. A-F were validated as per ICG guidelines. 
3.1 Linearity 
In methods A-F, delafloxacin displayed linearity in concentration range of 2- 
12 µg/mL.  The details of optical characteristics and linearity data is furnished 
in Table 1.
3.2 Recovery studies 
The accuracy of methods used was confirmed by with percentage recovery 
studies. The known amounts of SSS were added into the pre-analyzed sample 
solutions (4 µg/mL), at levels of 80, 100 and 120%.  The solutions were 
analyzed again using proposed methods, and the experiments were performed 
in triplicate at each level of all methods. The corresponding results are 
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Method precision was ensured analyzing inter- and intra-day deviation among 
experiments. For this purpose, the solutions of 4, 6 and 8 µg/mL of delafloxacin 
were analyzed, and deviation was noted (Table 2).
3.4 Sensitivity 
The sensitivity of delafloxacin measurement was determined in terms of 
LOD and LOQ denoted as limit of quantification and detection respectively. 
Table 1: The Optical Properties.
Criterion Method A Method B Method C Method D Method E Method F
Beer-Lambert’s 
range (µg/mL)








Slope 0.0835 0.5497 0.0226 0.1137 0.0038 0.0186
Intercept 0.0206 0.0927 0.0073 0.0011 0.0008 0.0011
Correlation 
coefficient
0.9992 0.9992 0.9993 0.9998 0.9991 0.9990
Table 2: Validation Parameters.
Parameters A B C D E F
Accuracy
80 % 100.07 100.59 98.95 98.99 97.86 98.90
100% 99.85 99.76 99.74 98.99 97.58 99.10





1.01-1.20 0.91-1.32 0.42-1.05 0.52-1.11 0.81-0.83 0.95-1.18
Interday 0.73-1.22 0.44-1.31 0.37-0.76 0.69-1.10 0.90-1.52 1.20-1.54
Repeatability  
(% RSD)
1.16 0.94 1.38 0.45 1.92 1.76
Ruggedness
(% RSD)
Analyst I 0.29 0.75 1.36 0.41 1.51 1.69
Analyst II 1.11 0.92 0.42 0.75 1.86 0.87
Limit of  
Detection
0.0472 0.0631 0.0581 0.0900 0.0750 0.0566
Limit of  
Quantification




The LOD and LOQ was calculated as per 3.3*N/B and 10*N/B equations 
respectively, wherein ‘N’ denoted standard deviation of absorbance, amplitude 
and peak areas of delafloxacin (n=3), taken as a measure of noise, and ‘B’ 
signifies the slope of corresponding calibration curve. Results are summarized 
in Table 2.
3.5 Repeatability 
Repeatability analysis was performed by analyzing 6 µg/mL delafloxacin 
solutions for six times for all methods (Table 2).
3.6 Ruggedness
The ruggedness of developed methods was analyzed with 6 µg/mL solution of 
delafloxacin through evaluation of aliquots from a homogenous lots, performed 
by two different analysts under similar operational and environmental 
conditions for all methods. The results were in an acceptable range that is % 
RSD values <2 for all methods (Table 2).
3.7 Analysis of Laboratory Mixture
Laboratory mixture of Delafloxacin was prepared by using common 
excipients. The 100 mg of drug was accurately weighted and taken into a 100 
mL volumetric flask containing Acetonitrile (50%), already sonicated for 15 
min, followed by volume make up to the mark and filtration using Whatmann 
filter paper (number 41). From this solution; an appropriate volumes of 0.3 
mL were diluted to 50 mL using same solution. The resulting solutions were 
scanned by using UV spectrophotometer in the range of 400-200 nm. The 
amounts of drug estimated using various proposed methods as determined 
from respective linearity equations and results are reported in Table 3.
4. RESULT AND DISCUSSION
In Acetonitrile (50%), delafloxacin displayed linearity for concentration range 
of 2-12 µg/mL. The maximum absorbance (λ max)/wavelength range and 
correlation coefficient for all methods given in Table 1. Laboratory mixture 
of delafloxacin were analyzed. The amounts of delafloxacin in mixture 
determined by all methods are given in Table 3. 
In all methods, inter- and intra-day precision was studied (% RSD less than 
2), and accuracy of all methods was determined calculating mean % recovery 
at 80, 100 and 120 % level. The results of accuracy study, repeatability, and 
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A total of six methods were established to analyze delafloxacin based on 
different UV spectrophotometric derivative and AUC methods. The established 
methods were quite simple, and duly validated in terms of accuracy, sensitivity 
and precision. As such, these methods can benefit other researchers, involved 
in similar studies, to perform routine analysis of delafloxacin in bulk material 
as well as in in laboratory mixture.
REFERENCES
[1] Abida, M. Imran, M. A. M. Hagga, S. A. El-Feky., (2014), New chemical entities of future 
for infectious diseases, European Journal of Experimental Biology, 4(1), 613–624.
[2] Bassetti M, Della Siega P, Pecori D, Scarparo C, Righi E., (2015), Delafloxacin for the treatment 
of respiratory and skin infections. Expert Opinion Investigational Drugs, 24(3), 433–442. 
http://dx.doi.org/10.1517/13543784.2015.1005205
[3] ICH Harmonized Tripartite Guideline, Q2 (R1): Validation of Analytical Procedures: Text 
and Methodology, International Conference on Harmonization, Geneva, Switzerland, 
2005.
[4] McEwen, L. Lawrence, R. Hoover, L. Stevens, S. Mair, G. Ford, et al, (2015),Disposition, 
metabolism and mass balance of delafloxacin in healthy human volunteers following 
intravenous administration, Xenobiotica, 1-9, doi:10.3109/00498254.2015.1042946. 
 http://dx.doi.org/10.3109/00498254.2015.1042946
[5] S. Chalikwar, A. Shirkhedkar, M. Bagul, P. Jain, S. Surana, (2012), Development and 
validation of zero and first-order derivative area under curve spectrophotometric methods 
for the determination of entacapone in bulk material and in tablets. Pharmceutical Methods, 
3(1), 14–17. http://dx.doi.org/10.4103/2229-4708.97709
[6] Van Bambeke F., (2015), Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of 
clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics 
and clinical efficacy. Future Microbiology, 10(7), 1111–23. 
 http://dx.doi.org/10.2217/fmb.15.39




A 5.9024   98.37 ± 1.39
B 5.9598   99.32 ± 1.55
C 5.8518   97.52 ± 1.07
D 6.0057 100.05 ± 1.15
E 6.0263 100.43 ± 1.51
F 5.8754   97.92 ± 1.61
